Optimization of de novo belatacept‐based immunosuppression administered to renal transplant recipients

Kidney transplant recipients administered belatacept‐based maintenance immunosuppression present with a more favorable metabolic profile, reduced incidence of de novo donor‐specific antibodies (DSAs), and improved renal function and long‐term patient/graft survival relative to individuals receiving...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirk, Allan D., Adams, Andrew B., Durrbach, Antoine, Ford, Mandy L., Hildeman, David A., Larsen, Christian P., Vincenti, Flavio, Wojciechowski, David, Woodle, E. Steve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Personal Viewpoints
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246831/
https://www.ncbi.nlm.nih.gov/pubmed/33128812
http://dx.doi.org/10.1111/ajt.16386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246831/
https://www.ncbi.nlm.nih.gov/pubmed/33128812
http://dx.doi.org/10.1111/ajt.16386

Ejemplares similares